Simultaneous Copy Number Alteration and Single-Nucleotide Variation Analysis in Matched Aqueous Humor and Tumor Samples in Children with Retinoblastoma.
Simultaneous Copy Number Alteration and Single-Nucleotide Variation Analysis in Matched Aqueous Humor and Tumor Samples in Children with Retinoblastoma.
复制标题
视网膜母细胞瘤儿童中匹配的水性幽默和肿瘤样本中的同时拷贝数改变和单核苷酸变异分析。
DOI:
10.3390/ijms24108606
复制
发表时间:
2023-05-11
影响因子:
5.6
通讯作者:
Berry, Jesse L.
中科院分区:
文献类型:
--
作者:
Schmidt, Michael J.;Prabakar, Rishvanth K.;Pike, Sarah;Yellapantula, Venkata;Peng, Chen-Ching;Kuhn, Peter;Hicks, James;Xu, Liya;Berry, Jesse L.
关键词:
Retinoblastoma (RB) is a childhood cancer that forms in the developing retina of young children; this tumor cannot be biopsied due to the risk of provoking extraocular tumor spread, which dramatically alters the treatment and survival of the patient. Recently, aqueous humor (AH), the clear fluid in the anterior chamber of the eye, has been developed as an organ-specific liquid biopsy for investigation of in vivo tumor-derived information found in the cell-free DNA (cfDNA) of the biofluid. However, identifying somatic genomic alterations, including both somatic copy number alterations (SCNAs) and single nucleotide variations (SNVs) of the RB1 gene, typically requires either: (1) two distinct experimental protocols—low-pass whole genome sequencing for SCNAs and targeted sequencing for SNVs—or (2) expensive deep whole genome or exome sequencing. To save time and cost, we applied a one-step targeted sequencing method to identify both SCNAs and RB1 SNVs in children with RB. High concordance (median = 96.2%) was observed in comparing SCNA calls derived from targeted sequencing to the traditional low-pass whole genome sequencing method. We further applied this method to investigate the degree of concordance of genomic alterations between paired tumor and AH samples from 11 RB eyes. We found 11/11 AH samples (100%) had SCNAs, and 10 of them (90.1%) with recurrent RB-SCNAs, while only nine out of 11 tumor samples (81.8%) had positive RB-SCNA signatures in both low-pass and targeted methods. Eight out of the nine (88.9%) detected SNVs were shared between AH and tumor samples. Ultimately, 11/11 cases have somatic alterations identified, including nine RB1 SNVs and 10 recurrent RB-SCNAs with four focal RB1 deletions and one MYCN gain. The results presented show the feasibility of utilizing one sequencing approach to obtain SCNA and targeted SNV data to capture a broad genomic scope of RB disease, which may ultimately expedite clinical intervention and be less expensive than other methods.
登录
查看更多内容
影响因子:
12.3
作者:
Kuilman T;Velds A;Kemper K;Ranzani M;Bombardelli L;Hoogstraat M;Nevedomskaya E;Xu G;de Ruiter J;Lolkema MP;Ylstra B;Jonkers J;Rottenberg S;Wessels LF;Adams DJ;Peeper DS;Krijgsman O
通讯作者:
Krijgsman O
影响因子:
3.7
作者:
Dunn P;Albury CL;Maksemous N;Benton MC;Sutherland HG;Smith RA;Haupt LM;Griffiths LR
通讯作者:
Griffiths LR
影响因子:
14.8
作者:
Kumar, Prateek;Henikoff, Steven;Ng, Pauline C.
通讯作者:
Ng, Pauline C.
影响因子:
4.2
作者:
Dimaras H;Corson TW
通讯作者:
Corson TW
影响因子:
7.9
作者:
通讯作者:
--